Second-generation antipsychotics in major depressive disorder: update and clinical perspective.


PURPOSE OF REVIEW The aim of this systematic review was to examine the efficacy and safety of second-generation antipsychotics (SGAs) in nonpsychotic major depressive disorder (MDD). RECENT FINDINGS In MDD, SGA monotherapy or adjunctive therapy to conventional antidepressants showed rapid onset of antidepressant efficacy. Although maintenance data are… (More)
DOI: 10.1097/YCO.0b013e3283413505


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.